Saomi Murai

463 total citations
17 papers, 347 citations indexed

About

Saomi Murai is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Saomi Murai has authored 17 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Biomedical Engineering. Recurrent topics in Saomi Murai's work include Cancer-related Molecular Pathways (7 papers), Balance, Gait, and Falls Prevention (3 papers) and Advanced Breast Cancer Therapies (2 papers). Saomi Murai is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Balance, Gait, and Falls Prevention (3 papers) and Advanced Breast Cancer Therapies (2 papers). Saomi Murai collaborates with scholars based in Japan, United States and Norway. Saomi Murai's co-authors include Shunsuke Ebara, Takahito Hara, Makoto Miyagishi, Shourong Wu, Megumi Hirayama, Yoshinori Satomi, Ayumi Ando, Kazunori Kataoka, Akito Hata and Maki Hasegawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Science Advances and Oncotarget.

In The Last Decade

Saomi Murai

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saomi Murai Japan 10 203 140 90 70 43 17 347
Keyu Gao China 7 239 1.2× 136 1.0× 155 1.7× 65 0.9× 64 1.5× 11 385
Gillian N. Kulikowski United States 8 231 1.1× 187 1.3× 63 0.7× 72 1.0× 41 1.0× 9 354
Kalle Ojala Finland 6 236 1.2× 85 0.6× 48 0.5× 76 1.1× 38 0.9× 12 334
Mansi Arora India 11 405 2.0× 189 1.4× 91 1.0× 96 1.4× 69 1.6× 19 544
Lucia García-Gutiérrez Spain 9 305 1.5× 132 0.9× 68 0.8× 62 0.9× 27 0.6× 15 417
Shiyi Yu China 12 257 1.3× 97 0.7× 49 0.5× 67 1.0× 33 0.8× 21 335
Sophie Lehn Sweden 9 194 1.0× 155 1.1× 63 0.7× 78 1.1× 62 1.4× 10 337
Mohammad Ahmad United States 11 237 1.2× 141 1.0× 33 0.4× 116 1.7× 35 0.8× 19 348
N Wong Hong Kong 7 179 0.9× 104 0.7× 48 0.5× 83 1.2× 52 1.2× 12 336
Ramona Rudalska Germany 4 351 1.7× 131 0.9× 71 0.8× 142 2.0× 33 0.8× 6 435

Countries citing papers authored by Saomi Murai

Since Specialization
Citations

This map shows the geographic impact of Saomi Murai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saomi Murai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saomi Murai more than expected).

Fields of papers citing papers by Saomi Murai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saomi Murai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saomi Murai. The network helps show where Saomi Murai may publish in the future.

Co-authorship network of co-authors of Saomi Murai

This figure shows the co-authorship network connecting the top 25 collaborators of Saomi Murai. A scholar is included among the top collaborators of Saomi Murai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saomi Murai. Saomi Murai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Iwai, Kenichi, Tadahiro Nambu, Yukie Kashima, et al.. (2021). A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery. Science Advances. 7(21). 19 indexed citations
2.
Iwai, Kenichi, Tadahiro Nambu, Jie Yu, et al.. (2019). Abstract A093: Potential combination partners for a novel CDC7-selective Inhibitor, TAK-931. Molecular Cancer Therapeutics. 18(12_Supplement). A093–A093. 1 indexed citations
3.
Nakamura, Akito, Daisuke Nakata, Saomi Murai, et al.. (2018). CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells. Oncotarget. 9(17). 13474–13487. 31 indexed citations
4.
Huang, Can, Shourong Wu, Hong Ji, et al.. (2017). Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library. Science Advances. 3(10). e1701383–e1701383. 44 indexed citations
5.
Fujimoto, Jun, Takaharu Hirayama, Yasuhiro Hirata, et al.. (2017). Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential. Bioorganic & Medicinal Chemistry. 25(12). 3018–3033. 16 indexed citations
6.
Ono, Koji, Hiroshi Banno, Masanori Okaniwa, et al.. (2017). Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3′,4′:3,4]benzo[1,2-d]isothiazole derivatives. Bioorganic & Medicinal Chemistry. 25(8). 2336–2350. 27 indexed citations
7.
Murai, Saomi, et al.. (2017). Aurora B Inhibitor TAK-901 Synergizes with BCL-xL Inhibition by Inducing Active BAX in Cancer Cells. Anticancer Research. 37(2). 437–444. 12 indexed citations
8.
Murai, Saomi, Ayumi Ando, Shunsuke Ebara, et al.. (2017). Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions. Oncogenesis. 6(5). e329–e329. 63 indexed citations
9.
Honda, Kohei, Hitoshi Miyashita, Saomi Murai, et al.. (2011). TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens. Molecular Cancer Therapeutics. 11(3). 700–709. 64 indexed citations
10.
Wu, Shourong, Saomi Murai, Kazunori Kataoka, & Makoto Miyagishi. (2007). Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1. Biochemical and Biophysical Research Communications. 365(1). 75–81. 26 indexed citations
11.
Wu, Shourong, Saomi Murai, Kazunori Kataoka, & Makoto Miyagishi. (2007). Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1. Nucleic Acids Symposium Series. 51(1). 347–348. 8 indexed citations
12.
Yasuoka, Y., et al.. (2005). Analysis of impulse response on walking stability using accelerometers. PubMed. 4. 4924–4927. 1 indexed citations
13.
Manandhar, Dharma, Kuniya Honda, & Saomi Murai. (2003). Accuracy assessment and improvement for level survey using real time kinematic (RTK) GPS. 2. 882–884. 8 indexed citations
14.
Shibasaki, Ryosuke, et al.. (2002). Analysis of impulse response on walking stability by a synchronized system of two accelerometers. 348–353. 4 indexed citations
15.
Minakuchi, Shunsuke, et al.. (2002). Analysis of 1/f fluctuation in walking using gyro sensor system. 77–82. 5 indexed citations
16.
Murai, Saomi. (1985). Asian conference on remote sensing. Photogrammetria. 40(2). 244–245. 17 indexed citations
17.
Murai, Saomi, et al.. (1971). Formation of a strip digital terrain model for the purpose of highway design. 10(2). 22–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026